nVerses Capital, LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 2011399 WELLINGTON, FL

Position in ESPR

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

+$0 QoQ

Shares Held

19,453

-71.2% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

nVerses Capital, LLC holds $1,009,100 across 5 Drug Manufacturers - Specialty & Generic names. ESPR ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	4,380	$349,217
2	HIMS	Hims & Hers Health, Inc.	7,093	$245,914
3	NBIX	Neurocrine Biosciences Inc	1,259	$212,191
4	COLL	Collegium Pharmaceutical, Inc	5,574	$201,778
5	ESPR	Esperion Therapeutics, Inc. This page	19,453	$0

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	19,453	-71.2%	Shares	Sole	2026-08-04
2025-12-31	—	67,450	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.